Kathleen Dorritie

Also affiliated with UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia”.

Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0029

N/A

1.4DataRank · unranked

34 citations

Tianyu Cai, Xia Li, Xiaoli Huang, Mai H. Bui, Joshua P. Plotnik +26 more

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2172981

N/A

0DataRank · unranked

0 citations

Anastasia Tsagianni, Mounzer Agha, Anastasios Raptis, Jing‐Zhou Hou, Rafic Farah +10 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0DataRank · unranked

74 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more